A detailed history of Patrick M Sweeney & Associates, Inc transactions in Amgen Inc stock. As of the latest transaction made, Patrick M Sweeney & Associates, Inc holds 991 shares of AMGN stock, worth $291,354. This represents 0.23% of its overall portfolio holdings.

Number of Shares
991
Previous 991 -0.0%
Holding current value
$291,354
Previous $310 Million 3.12%
% of portfolio
0.23%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $17,745 - $21,420
66 Added 7.14%
991 $282 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $236,522 - $266,825
925 New
925 $266 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Patrick M Sweeney & Associates, Inc Portfolio

Follow Patrick M Sweeney & Associates, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patrick M Sweeney & Associates, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patrick M Sweeney & Associates, Inc with notifications on news.